XT
GDTC icon

XTX Topco’s CytoMed Therapeutics GDTC Stock Holding History

XTX Topco’s Portfolio GDTC Stock Details GDTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1K Buy
+10,136
New +$10.7K ﹤0.01% 3682

Other funds holding GDTC

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

XTX Topco's GDTC Position: Q1 2026 in Review

XTX Topco opened a new position in CytoMed Therapeutics (GDTC) in Q1 2026: 10,136 shares worth $10.1K. The stake represents ﹤0.01% of the portfolio and ranks #3682 among its holdings.

3 funds tracked by Wall St. Rank hold GDTC as of Q1 2026.

  • XTX Topco held 10,136 shares of CytoMed Therapeutics worth $10.1K as of Q1 2026.
  • CytoMed Therapeutics was a new XTX Topco position in Q1 2026.
  • CytoMed Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3682 holding.
  • 3 funds tracked by Wall St. Rank held CytoMed Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.